Inspire Investing’s Alaunos Therapeutics TCRT Stock Holding History

Inspire Investing’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20	Hold	9	–	–	﹤0.01%	1255
2026 Q1	$25	Sell	9 -1	-10%	-$3	﹤0.01%	1092
2025 Q4	$34	Buy	+10	New	+$32	﹤0.01%	1085
2020 Q2	–	Sell	-1	Closed	–	–	695
2020 Q1	$0	Buy	+1	New	+$517	﹤0.01%	792
2018 Q1	–	Sell	-1	Closed	-$1K	–	642
2017 Q4	$1K	Buy	+1	New	+$718	﹤0.01%	885

Other funds holding TCRT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Inspire Investing's TCRT Position: Q2 2026 in Review

Inspire Investing held its Alaunos Therapeutics (TCRT) position steady in Q2 2026 at 9 shares worth $20. The position accounts for ﹤0.01% of the portfolio, ranked #1255.

Inspire Investing first reported a position in TCRT in Q4 2017 and has held it in 5 quarters since. The position peaked at $1K in Q4 2017. 29 funds tracked by Wall St. Rank hold TCRT as of Q2 2026.

Inspire Investing held 9 shares of Alaunos Therapeutics worth $20 as of Q2 2026.
Inspire Investing left its Alaunos Therapeutics share count unchanged in Q2 2026.
Alaunos Therapeutics made up ﹤0.01% of Inspire Investing's portfolio in Q2 2026, its #1255 holding.
Inspire Investing first reported a position in Alaunos Therapeutics in Q4 2017 and has held it in 5 quarters since.
Inspire Investing's Alaunos Therapeutics position peaked at $1K in Q4 2017.
29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.